Emerald Acquisition Ltd. bought a new stake in Orthofix International NV (NASDAQ:OFIX) during the second quarter, Holdings Channel reports. The fund bought 104,577 shares of the medical device company’s stock, valued at approximately $4,435,000. Emerald Acquisition Ltd. owned approximately 0.57% of Orthofix International NV as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in OFIX. Bank of Montreal Can acquired a new stake in Orthofix International NV during the second quarter valued at approximately $456,000. Acadian Asset Management LLC boosted its stake in Orthofix International NV by 25.1% in the second quarter. Acadian Asset Management LLC now owns 660,196 shares of the medical device company’s stock valued at $27,993,000 after buying an additional 132,537 shares in the last quarter. Royal Bank of Canada boosted its stake in Orthofix International NV by 28.0% in the first quarter. Royal Bank of Canada now owns 12,913 shares of the medical device company’s stock valued at $536,000 after buying an additional 2,828 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Orthofix International NV by 78.7% in the first quarter. Renaissance Technologies LLC now owns 456,379 shares of the medical device company’s stock valued at $18,949,000 after buying an additional 201,020 shares in the last quarter. Finally, Bogle Investment Management L P DE boosted its stake in Orthofix International NV by 37.6% in the first quarter. Bogle Investment Management L P DE now owns 81,833 shares of the medical device company’s stock valued at $3,397,000 after buying an additional 22,365 shares in the last quarter. 92.41% of the stock is owned by institutional investors and hedge funds.

Shares of Orthofix International NV (NASDAQ:OFIX) traded down 0.98% during midday trading on Friday, reaching $44.48. The company’s stock had a trading volume of 121,436 shares. The stock has a 50-day moving average price of $44.24 and a 200-day moving average price of $43.56. The stock’s market cap is $806.16 million. Orthofix International NV has a 52-week low of $32.25 and a 52-week high of $48.25.

Orthofix International NV (NASDAQ:OFIX) last posted its quarterly earnings data on Monday, August 1st. The medical device company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.08. Orthofix International NV had a positive return on equity of 8.50% and a negative net margin of 0.37%. The firm earned $104.10 million during the quarter, compared to analysts’ expectations of $102.40 million. During the same period in the prior year, the business earned $0.36 EPS. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts anticipate that Orthofix International NV will post $1.41 earnings per share for the current fiscal year.

Several research firms recently commented on OFIX. Zacks Investment Research cut Orthofix International NV from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. TheStreet cut Orthofix International NV from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd.

In other news, insider Michael Finegan sold 25,000 shares of the business’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $45.16, for a total value of $1,129,000.00. Following the completion of the sale, the insider now owns 51,670 shares of the company’s stock, valued at approximately $2,333,417.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 5.10% of the stock is owned by insiders.

Orthofix International NV Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

5 Day Chart for NASDAQ:OFIX

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International NV (NASDAQ:OFIX).

Receive News & Ratings for Orthofix International NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International NV and related companies with Analyst Ratings Network's FREE daily email newsletter.